One particularly appealing dividend stock right now is Bristol Myers Squibb ( BMY 0.10%). It yields 5.4%, which is an ...

The stock of biotech Arrowhead Pharmaceuticals ( ARWR +23.34%) experienced a serious Hump Day jump. On the Wednesday before Thanksgiving, the company's shares rose by more than 23%, thanks largely to ...

Jazz Pharmaceuticals plc stock jumped on positive Ziihera trial results. Click for my updated look at JAZZ stock and see why ...

JNJ’s stock has risen by almost 45%, whereas PFE has declined by 6%, greatly exceeding the S&P 500's 13% increase.

As of Friday, November 07, Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 13.64%, which has investors questioning if this is right time to buy.

As of Wednesday, November 26, Arrowhead Pharmaceuticals, Inc.’s ARWR share price has surged by 9.30%, which has investors ...

Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations ...

AI breakthroughs in pharma are pushing Eli Lilly and healthcare stocks higher—and may soon reshape how we fight cancer.

Large pharma companies are facing severe patent cliffs, where blockbuster drugs lose exclusivity and revenue plummets.

Zydus Lifesciences on Thursday said it has received approval from the US health regulator to market a generic diabetes drug.

As the Indian Rupee hits 90 per USD, analysts recommend investing in in export-driven sectors such as IT and Pharma ...

CDMO-linked chemical makers are pulling ahead as tariff shocks, Chinese oversupply, and weak global demand hit the broader ...